KEWAUNEE SCIENTIFIC CORP /DE/
Financial highlights
| Metric | FY 04/30/25 | FY 04/30/24 | FY 04/30/23 | FY 04/30/22 | FY 04/30/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $240.5M | $203.8M | $219.5M | $168.9M | $147.5M |
| Cost of revenue | $171.6M | $151.7M | $183.9M | $144.7M | $123.5M |
| Gross profit | $68.9M | $52.1M | $35.6M | $24.2M | $24.0M |
| Research and development | $919,000 | $920,000 | $1.0M | $990,000 | $1.4M |
| Operating expenses | $51.1M | $33.8M | $30.2M | $26.8M | $25.3M |
| Operating income | $17.8M | $18.3M | $5.4M | -$2.6M | -$1.3M |
| Interest expense | $3.2M | $1.8M | $1.7M | $632,000 | $389,000 |
| Pretax income | $14.8M | $13.1M | $4.5M | -$2.5M | -$2.6M |
| Income tax expense | $3.2M | -$5.9M | $3.1M | $3.5M | $990,000 |
| Net income | $11.4M | $18.8M | $738,000 | -$6.1M | -$3.7M |
| Balance Sheet | |||||
| Cash and equivalents | $14.9M | $23.3M | $8.1M | $4.4M | $5.2M |
| Current assets | $118.4M | $96.8M | $87.9M | $91.6M | $60.5M |
| Total assets | $194.7M | $134.8M | $118.9M | $118.8M | $89.4M |
| Current liabilities | $53.7M | $40.8M | $40.1M | $42.3M | $34.2M |
| Total liabilities | $128.4M | $78.6M | $80.4M | $82.6M | $47.9M |
| Stockholders' equity | $64.5M | $54.8M | $37.4M | $35.7M | $41.2M |
| Cash Flow Statement | |||||
| Cash from operations | $14.8M | $19.6M | -$3.8M | -$7.9M | $912,000 |
| Depreciation and amortization | $4.8M | $3.1M | $2.9M | $2.8M | $2.7M |
| Stock-based compensation | $1.4M | $1.0M | $886,000 | $729,000 | $634,000 |
| Capital expenditure | $2.2M | $4.4M | $4.1M | $1.9M | $2.4M |
| Free cash flow | $12.6M | $15.2M | -$7.9M | -$9.8M | -$1.5M |
| Dividends paid | — | — | — | — | $0 |
| Share repurchases | $1.6M | $2.0M | $0 | — | — |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 2.9M · Free float 71.5%
Annual filing data through FY ended April 30, 2025; float as of July 8, 2026.